Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Barnes & Noble, Inc. (BKS): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Page 1 of 2

Is Barnes & Noble, Inc. (NYSE:BKS) an excellent investment now? Prominent investors are getting more optimistic. The number of bullish hedge fund bets inched up by 1 lately.

In the financial world, there are a multitude of indicators shareholders can use to watch stocks. A duo of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite investment managers can beat the market by a solid amount (see just how much).

Barnes & Noble, Inc. (NYSE:BKS)Just as integral, positive insider trading activity is another way to parse down the marketplace. There are lots of stimuli for a bullish insider to drop shares of his or her company, but only one, very obvious reason why they would buy. Several academic studies have demonstrated the valuable potential of this strategy if investors understand where to look (learn more here).

With these “truths” under our belt, we’re going to take a gander at the latest action encompassing Barnes & Noble, Inc. (NYSE:BKS).

How are hedge funds trading Barnes & Noble, Inc. (NYSE:BKS)?

At the end of the first quarter, a total of 20 of the hedge funds we track held long positions in this stock, a change of 5% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes substantially.

When looking at the hedgies we track, Kingstown Capital Management, managed by Michael Blitzer, holds the biggest position in Barnes & Noble, Inc. (NYSE:BKS). Kingstown Capital Management has a $24.7 million position in the stock, comprising 4.5% of its 13F portfolio. Coming in second is SAC Capital Advisors, managed by Steven Cohen, which held a $18.3 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other peers with similar optimism include Michael Price’s MFP Investors, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and Eliav Assouline and Marc Andersen’s Axial Capital.

As one would reasonably expect, specific money managers have been driving this bullishness. Axial Capital, managed by Eliav Assouline and Marc Andersen, created the biggest position in Barnes & Noble, Inc. (NYSE:BKS). Axial Capital had 6.5 million invested in the company at the end of the quarter. John A. Levin’s Levin Capital Strategies also initiated a $5.3 million position during the quarter. The following funds were also among the new BKS investors: Thomas A. Giovine’s Giovine Capital, Matthew Hulsizer’s PEAK6 Capital Management, and SAC Subsidiary’s CR Intrinsic Investors.

How have insiders been trading Barnes & Noble, Inc. (NYSE:BKS)?

Insider purchases made by high-level executives is best served when the primary stock in question has seen transactions within the past half-year. Over the latest 180-day time period, Barnes & Noble, Inc. (NYSE:BKS) has seen zero unique insiders buying, and 3 insider sales (see the details of insider trades here).

Let’s go over hedge fund and insider activity in other stocks similar to Barnes & Noble, Inc. (NYSE:BKS). These stocks are Francesca’s Holdings Corp (NASDAQ:FRAN), EZCORP Inc (NASDAQ:EZPW), Office Depot Inc (NYSE:ODP), OfficeMax Inc (NYSE:OMX), and Finish Line Inc (NASDAQ:FINL). This group of stocks are in the specialty retail, other industry and their market caps resemble BKS’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!